International reference pricing is one of the most important tools in drug price management and payment management.European Union countries,Japan,and the United States have adopted the international reference pricing for drugs.China is implementing drug price management,committing to new drug launch prices,and referencing external prices for initial pricing.It is suggested that international reference pricing for drugs be piloted in innovative drugs and gradually extended to drugs reimbursed by medical insurance.Implementation rules,audit and supervision mechanisms should be introduced to improve the comprehensive system of price governance.
万方数据